BioNTech, Pfizer Say They Didn't Infringe CureVac Patents

By Hailey Konnath · July 25, 2022, 10:54 PM EDT

BioNTech and Pfizer on Monday asked a Massachusetts federal court to find that they haven't infringed CureVac patents related to COVID-19 vaccine technology, claiming that the drugmakers are facing threats of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

BioNTech SE et al v. CureVac AG

Case Number

Court

Massachusetts

Nature of Suit

Patent

Date Filed

July 25, 2022

Recent Articles By Hailey

July 26, 2024
Apple Commits To White House Guidelines For Responsible AI
July 22, 2024
AbbVie Challenges Mo. Drug Discount Program Requirements
July 12, 2024
Feds Say Former Hospital CFO, 2 Others Embezzled $15M
July 05, 2024
9th Circ. Backs Remand Of Cedars-Sinai Patient Data Suits
July 03, 2024
HHS Scores Early Win In Boehringer's Medicare Pricing Suit
July 01, 2024
State AGs Get Stay Lifted In Generic Drug Pricing Litigation
June 27, 2024
OptumRx Agrees To Pay $20M To Resolve DOJ Opioid Claims
June 27, 2024
ACLU Says Mich. Can't Ban Medicaid Coverage Of Abortions
June 18, 2024
Novant Pays $6.7M For Sharing Patient Data With Facebook
June 10, 2024
Baltimore Lands $45M Deal With Allergan In Opioid Litigation